Autor segons l'article: Biosca-Brull, J; Ona, G; Alarcon-Franco, L; Colomina, MT
Departament: Antropologia, Filosofia i Treball Social Psicologia
Autor/s de la URV: Biosca Brull, Judit / Colomina Fosch, Maria Teresa / Oña Esteve, Genís
Paraules clau: Naloxone-precipitated withdrawal vasopressin rats oxytocin morphine-withdrawal lysergic-acid diethylamide gene-expression cell-proliferation brain addiction drug ibogaine
Resum: Ibogaine (IBO) is an atypical psychedelic with a complex mechanism of action. To date, the mechanisms that may underlie its anti-addictive effects are still not defined. This study aims to identify changes in gene expression induced by a single oral dose of IBO in the cortex of mice by means of a transcriptomic analysis for the first time. Our results showed significant alterations in gene expression in mouse frontal cortex samples 4 h after a single oral dose of IBO. Specifically, genes involved in hormonal pathways and synaptogenesis exhibited upregulation, while genes associated with apoptotic processes and endosomal transports showed downregulation. The findings were further corroborated through quantitative polymerase chain reaction (qPCR) analysis. However, the validation of gene expression related to hormonal pathways did not entirely align with the transcriptomic analysis results, possibly due to the brain region from which tissue was collected. Sex differences were observed, with female mice displaying more pronounced alterations in gene expression after IBO treatment. High variability was observed across individual animals. However, this study represents a significant advancement in comprehending IBO's molecular actions. The findings highlight the influence of IBO on gene expression, particularly on hormonal pathways, synaptogenesis, apoptotic processes, and endosomal transports. The identification of sex differences underscores the importance of considering sex as a potential factor influencing IBO's effects. Further research to assess different time points after IBO exposure is warranted.© 2024. The Author(s).
Àrees temàtiques: Saúde coletiva Psychiatry and mental health Psychiatry Psicología Nutrição Medicina ii Medicina i Linguística e literatura Interdisciplinar Engenharias iv Enfermagem Educação física Ciências biológicas ii Ciências biológicas i Cellular and molecular neuroscience Biotecnología Biological psychiatry
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: genis.ona@urv.cat genis.ona@urv.cat judit.biosca@urv.cat judit.biosca@urv.cat mariateresa.colomina@urv.cat
Identificador de l'autor: 0000-0002-5619-4874
Data d'alta del registre: 2024-08-03
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://www.nature.com/articles/s41398-024-02773-7
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Translational Psychiatry. 14 (1): 41-41
Referència de l'ítem segons les normes APA: Biosca-Brull, J; Ona, G; Alarcon-Franco, L; Colomina, MT (2024). A transcriptomic analysis in mice following a single dose of ibogaine identifies new potential therapeutic targets. Translational Psychiatry, 14(1), 41-41. DOI: 10.1038/s41398-024-02773-7
DOI de l'article: 10.1038/s41398-024-02773-7
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2024
Tipus de publicació: Journal Publications